Transplantation with selected autologous peripheral blood CD34 + Thy1 + hematopoietic stem cells in multiple myeloma - The issue of safety

By Sica S.   Sora F.   Chiusolo P.   Cicconi S.   Piccirillo N.   Cattani P.   Laurenti L.   Leone G.  

Experimental Hematology, Vol. 29, Iss. 1, 2001-01 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Transplantation with selected autologous peripheral blood CD34 + Thy1 + hematopoietic stem cells (HSCs) in multiple myeloma - Impact of HSC dose on engraftment, safety, and immune reconstitution

By Michallet M.   Philip T.   Philip I.   Godinot H.   Sebban C.   Salles G.   Thiebaut A.   Biron P.   Lopez F.   Mazars P.   Roubi N.   Leemhuis T.   Hanania E.   Reading C.   Fine G.   Atkinson K.   Juttner C.   Coiffier B.   Fiere D.   Archimbaud  

Experimental Hematology, Vol. 28, Iss. 7, 2000-07 ,pp. : 858-870

Elsevier

Access to resources Recommend Favorite

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

By Hicks C.   Wong R.   Manoharan A.   Kwan Y.  

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 591-598

Springer Publishing Company

Access to resources Recommend Favorite

Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma

By Li Yangqiu   Chen Shaohua   Yang Lijian   Chen Si   Lin Chunlan   Wang Liang   Lu Yuhong   Geng Suxia   Du Xin   Schmidt Christian A  

Hematology, Vol. 16, Iss. 3, 2011-05 ,pp. : 143-149

Maney Publishing

Access to resources Recommend Favorite

The proportion of CD16+CD14dim monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma

By  

Immunity, Inflammation And Disease, Vol. 3, Iss. 2, 2015-06 ,pp. : 94-102

John Wiley & Sons Inc

Access to resources Recommend Favorite